Stroes, E., Guyton, J. R., Lepor, N., Civeira, F., Gaudet, D., Watts, G. F., . . . Mathews, R. (2016). Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study. J Am Heart Assoc.
Chicago-стиль цитированияStroes, Erik, et al. "Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not On Statin Therapy: The ODYSSEY CHOICE II Study." J Am Heart Assoc 2016.
MLA-цитированиеStroes, Erik, et al. "Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not On Statin Therapy: The ODYSSEY CHOICE II Study." J Am Heart Assoc 2016.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.